Article

Restoring aqueous flow in early glaucoma

Robert Stegmann, MD, has spent years working on a procedure to reverse glaucoma. He demonstrated the results of canaloplasty to reinstitute aqueous flow in eyes with no flow and severely high IOP values. Dr. Stegmann, professor and chairman, Medical University of South Africa, Pretoria, delivered the Stephen A. Obstbaum, MD, Honored Lecture, titled "The Time Has Come, the Walrus Said . . . to Cure Glaucoma."

Chicago-Robert Stegmann, MD, has spent years working on a procedure to reverse glaucoma. He demonstrated the results of canaloplasty to reinstitute aqueous flow in eyes with no flow and severely high IOP values. Dr. Stegmann, professor and chairman, Medical University of South Africa, Pretoria, delivered the Stephen A. Obstbaum, MD, Honored Lecture, titled “The Time Has Come, the Walrus Said . . . to Cure Glaucoma.”

Dr. Stegmann demonstrated in detail his technique that uses a canal expander to restore normal physiologic function to the entire length of Schlemm’s canal in eyes with early glaucoma. Extensive follow-up has shown that with restitution of the physiological function, normalization of the cup is realized.

In many of his cases, the IOP levels were in the 30s and following surgery normalized to from 9 to 12 mm Hg.  He showed cases in which after 15 or 21 years of follow-up, the cupping has not increased and the IOPs have remained low.

“Early intervention can turn the disease around completely,” Dr. Stegmann said. “Operate early. Determine the diagnosis. If you can visualize two collector channels, you can achieve IOPs of 9 to 12 mm Hg. If you find only one, you can achieve 18 mm Hg. The earlier you operate the better are the chances of finding two.”

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.